ResearcherInstitució Catalana de Recerca i Estudis AvançatsActive in the last 2 years

Susana de la Luna

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7765-916X; OpenAlex author ID A5076690926. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cristina Fillat · 2 shared papers, 2019–2026 · strength 0.43
- Paper DYRK1A coordinates tumor–stroma secretory programs that promote an immunosuppressive microenvironment in pancreatic can… DOI 10.1038/s41420-026-03444-w ↗
- Paper DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. DOI 10.1136/gutjnl-2018-316128 ↗
Silvia Pascual-Sabater · 1 shared paper, 2026 · strength 0.33
- Paper DYRK1A coordinates tumor–stroma secretory programs that promote an immunosuppressive microenvironment in pancreatic can… DOI 10.1038/s41420-026-03444-w ↗
Jeroni Luna · 1 shared paper, 2019 · strength 0.09
- Paper DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. DOI 10.1136/gutjnl-2018-316128 ↗
Meritxell Gironella · 1 shared paper, 2019 · strength 0.09
- Paper DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. DOI 10.1136/gutjnl-2018-316128 ↗
Eva Cristina Vaquero · 1 shared paper, 2019 · strength 0.09
- Paper DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. DOI 10.1136/gutjnl-2018-316128 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.